Skip to main
NEOG

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Neogen Corporation is positioned positively within the food and animal safety sectors, leveraging its comprehensive product portfolio that addresses critical public health concerns such as foodborne illnesses and biosecurity in livestock. The company's recent acquisition has notably enhanced its market presence, indicating a strategic move towards growth through expansion and innovation. Despite facing competition and supply chain vulnerabilities, Neogen’s strong focus on internal growth and strategic acquisitions supports a favorable outlook for its financial performance.

Bears say

Neogen Corporation has faced challenges reflected in its recent financial performance, with revenue growth stagnating amid increasing competition and rising operational costs. The company's heavy reliance on regulatory approvals for its products has resulted in unpredictable timelines and potential delays in launching new offerings, adversely impacting its market position. Additionally, Neogen's profit margins have been constrained due to ongoing investments in research and development, which may not yield immediate returns, further contributing to a negative financial outlook.

Neogen (NEOG) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 3 analysts, Neogen (NEOG) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.